Pityriasis rosea as a leading manifestation of COVID-19 infection.
作者信息
Merhy R, Sarkis A S, Stephan F
机构信息
Department of Dermatology, Hotel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
出版信息
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e246-e247. doi: 10.1111/jdv.17052. Epub 2020 Dec 23.
Abstract
摘要
相似文献
1
Pityriasis rosea as a leading manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e246-e247. doi: 10.1111/jdv.17052. Epub 2020 Dec 23.
2
Pityriasis rosea-like eruption revealing COVID-19.
Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504. Epub 2020 Nov 20.
3
A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection.
Pediatr Dermatol. 2011 May-Jun;28(3):341-2. doi: 10.1111/j.1525-1470.2010.01090.x. Epub 2010 Apr 9.
4
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
5
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
6
Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Med Clin (Barc). 2020 Sep 25;155(6):273. doi: 10.1016/j.medcli.2020.05.024. Epub 2020 Jun 5.
7
Investigation of herpes simplex virus DNA in pityriasis rosea by polymerase chain reaction.
Int J Dermatol. 2005 Jun;44(6):477-8. doi: 10.1111/j.1365-4632.2005.01965.x.
8
Pityriasis rosea--evidence for and against an infectious aetiology.
Epidemiol Infect. 2004 Jun;132(3):381-90. doi: 10.1017/s0950268804002304.
9
Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment.
J Med Virol. 2022 Jul;94(7):2915-2916. doi: 10.1002/jmv.27672. Epub 2022 Mar 6.
10
Recurrence of hepatitis C virus infection during pityriasis rosea.
Acta Derm Venereol. 2013 Jul 6;93(4):483. doi: 10.2340/00015555-1509.
引用本文的文献
1
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
2
Cutaneous Eruptions in the Course of COVID-19 Among Geriatric Patients in a Nursing Home in Poland.
Clin Cosmet Investig Dermatol. 2022 Oct 4;15:2117-2127. doi: 10.2147/CCID.S371630. eCollection 2022.
3
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
4
SARS-CoV-2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?
J Med Virol. 2022 Nov;94(11):5103-5111. doi: 10.1002/jmv.27994. Epub 2022 Jul 22.
5
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
6
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.
Clin Dermatol. 2021 Nov-Dec;39(6):934-965. doi: 10.1016/j.clindermatol.2021.07.001. Epub 2021 Jul 22.
7
Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series.
Dermatol Ther. 2022 Feb;35(2):e15225. doi: 10.1111/dth.15225. Epub 2021 Dec 1.
8
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
9
Clinical Patterns and Morphology of COVID-19 Dermatology.
Dermatol Clin. 2021 Oct;39(4):487-503. doi: 10.1016/j.det.2021.05.006. Epub 2021 May 31.
10
The effect of the COVID-19 pandemic on dermatology consultation requests from adult and paediatric emergency departments.
Int J Clin Pract. 2021 Dec;75(12):e14906. doi: 10.1111/ijcp.14906. Epub 2021 Sep 27.
本文引用的文献
1
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
2
Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Med Clin (Engl Ed). 2020 Sep 25;155(6):273. doi: 10.1016/j.medcle.2020.05.017. Epub 2020 Sep 4.
3
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.
J Am Acad Dermatol. 2020 Oct;83(4):1118-1129. doi: 10.1016/j.jaad.2020.06.1016. Epub 2020 Jul 2.
4
Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e686-e689. doi: 10.1111/jdv.16775. Epub 2020 Jul 20.
5
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
Zotero 插件